Ascendis Pharma A/S DSO Ratio 2011-2026 | ASND

Annual DSO Ratio Ascendis Pharma A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	132	98.3	62	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
132	62	97.5

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Altimmune ALT	15.1 K	$ 4.2	-2.67 %	$ 298 M	USA
Apellis Pharmaceuticals APLS	115	$ 20.24	-3.44 %	$ 2.55 B	USA
Aptorum Group Limited APM	20.6	$ 0.8	1.87 %	$ 4.36 M	China
Aptevo Therapeutics APVO	79	$ 7.2	-1.64 %	$ 1.99 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Aquestive Therapeutics AQST	50.1	$ 4.1	2.37 %	$ 356 M	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Arcturus Therapeutics Holdings ARCT	43.2	$ 8.35	1.46 %	$ 225 M	Israel
Ardelyx ARDX	58	$ 6.37	-2.75 %	$ 1.54 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Armata Pharmaceuticals ARMP	249	$ 10.91	1.58 %	$ 394 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	106	$ 25.33	-6.1 %	$ 3.22 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Arvinas ARVN	4.66	$ 12.97	-2.3 %	$ 920 M	USA
Arrowhead Pharmaceuticals ARWR	8.75	$ 61.74	-2.42 %	$ 8.26 B	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.39	-1.63 %	$ 8.16 B	Australia
Atossa Therapeutics ATOS	207	$ 4.39	-0.9 %	$ 553 M	USA
Atara Biotherapeutics ATRA	50.4	$ 5.01	-7.47 %	$ 37.5 M	USA
Aurinia Pharmaceuticals AUPH	185	$ 14.14	-0.21 %	$ 1.9 B	Canada
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Axon Enterprise AXON	134	$ 570.5	5.18 %	$ 43.2 B	USA
Axsome Therapeutics AXSM	105	$ 162.28	-0.98 %	$ 8.07 B	USA
Aytu BioScience AYTU	150	$ 2.56	-0.58 %	$ 16.1 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA